ArticleRheumatology (Oxford, England)2022

Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis.

Peter Nash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.